Journal of Translational Medicine · 2013 · 105 citations · 42 references
MedicineImmunologyOncologyCancer ImmunologyInnate ImmunityTumor MicroenvironmentCancer ImmunosurveillanceCancer ImmunotherapyImmuno-oncology BiomarkersNatural Killer Cell BiologyNatural Killer Cell RegulationTumor Immune MicroenvironmentBreast Cancer PrognosisImmune Biomarker ProfilingImmune-mediated Tissue DestructionInnate Immune Signaling GenesNatural Killer Cell Inhibitory SignalingNk Cell Activating LigandsPrognostic Signature DevelopmentRelapse-free Survival
BACKGROUND: Recent observations suggest that immune-mediated tissue destruction is dependent upon coordinate activation of immune genes expressed by cells of the innate and adaptive immune systems. METHODS: Here, we performed a retrospective pilot study to investigate whether the coordinate expression of molecular signature mostly associated with NK cells could be used to segregate breast cancer patients into relapse and relapse-free outcomes. RESULTS: By analyzing primary breast cancer specimens derived from patients who experienced either 58-116 months (~5-9 years) relapse-free survival or developed tumor relapse within 9-76 months (~1-6 years) we found that the expression of molecules involved in activating signaling of NK cells and in NK cells: target interaction is increased in patients with favorable prognosis. CONCLUSIONS: The parameters identified in this study, together with the prognostic signature previously reported by our group, highlight the cooperation between the innate and adaptive immune components within the tumor microenvironment.
42
Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome
Jérôme Galon, Anne Costes, Fátima Sánchez‐Cabo et al. · Science · 2006 · 6.5K citations
Medicine, Immunology, Oncology +17
Lance D. Miller, Johanna Smeds, Joshy George et al. · Proceedings of the National Academy of Sciences · 2005 · 1.3K citations · Full text